MedPath

Clinical and Functional Consequences of Photodynamic Diagnosis (PDD) and Intravesical Instillation Therapy

Active, not recruiting
Conditions
Non-muscle Invasive Bladder Cancer
Interventions
Other: Urodynamic examination
Registration Number
NCT04943094
Lead Sponsor
Aarhus University Hospital
Brief Summary

The aim is to evaluate and compare treatment strategies for non-muscle invasive bladder cancer. Furthermore, the impact of intravesical instillations on bladder function will be examined by urodynamic examination both prior to and following instillation therapy.

Detailed Description

Not available

Recruitment & Eligibility

Status
ACTIVE_NOT_RECRUITING
Sex
All
Target Recruitment
50
Inclusion Criteria
  • non-muscle invasive bladder tumour
Exclusion Criteria
  • more than one previous bladder tumour recurrence
  • muscle invasive bladder cancer (at baseline or prior to inclusion)
  • utilization of urinary catheter
  • have had heart valve replacement performed
  • pregnant or lactating

Study & Design

Study Type
OBSERVATIONAL
Study Design
Not specified
Arm && Interventions
GroupInterventionDescription
TURBT and mitomycin CUrodynamic examinationPatients treated with TURBT followed by six adjuvant instillations with mitomycin C
TURBT aloneUrodynamic examinationPatients treated with TURBT without adjuvant instillation therapy
TURBT and bacillus Calmette-GuerinUrodynamic examinationPatients treated with TURBT followed by six adjuvant instillations with BCG
Primary Outcome Measures
NameTimeMethod
Change in urodynamic specifics (bladder compliance, detrusor overactivity, maximal cystometric capacity)examined at time 0 and after six months

Obtained from the urodynamic test

Secondary Outcome Measures
NameTimeMethod

Trial Locations

Locations (1)

Aarhus University Hospital

🇩🇰

Aarhus, Denmark

© Copyright 2025. All Rights Reserved by MedPath